Examination of effector CD4+ T cells during the period associated with the development of peritoneal fibrosis (days 28–49) showed that this Th1 cell phenotype was maintained and represented the most prominent CD4+ T cell population within the peritoneal cavity (Figure S5). The gene discussed is CD4; the disease is Peritoneal Fibrosis.